FDA issues new warning on rare autoimmune disorder linked to J&J vaccine
(WASHINGTON) — The U.S. Food and Drug Administration on Monday warned of an increased risk of Guillain-Barre, a rare neurological disorder, following the Johnson & Johnson vaccine after 100 preliminary cases of the syndrome were reported among the 12.5M doses administered.The agency noted that... Read More.